Comparing Efficacy and Safety of TJO-083 in Dry Eye Disease Patients

NCT05346783 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: TJO-083
OTHER: Placebo (vehicle)
DRUG: Diquafosol ophthalmic sodium solution 3%

Sponsor

Taejoon Pharmaceutical Co., Ltd.